CD64 was expressed in several APL cases in our cohort; therefore, a CD34-negative HLA-DR-negative AML, that expresses CD64 over log 1 or higher, should be regarded as highly suspicious for APL. This evidence concerns the gene FCGR1A and acute promyelocytic leukemia.